Common Stock, Shares, Outstanding of Cue Biopharma, Inc. from 31 Dec 2017 to 31 Dec 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Cue Biopharma, Inc. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2017 to 31 Dec 2025.
  • Cue Biopharma, Inc. Common Stock, Shares, Outstanding for the quarter ending 31 Dec 2025 was 96,621,218, a 56% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

Cue Biopharma, Inc. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2025 96,621,218 +34,802,117 +56% 31 Dec 2025 10-K 16 Mar 2026 2025 FY
Q3 2025 77,781,743 +17,574,026 +29% 30 Sep 2025 10-Q 12 Nov 2025 2025 Q3
Q2 2025 76,446,884 +27,803,568 +57% 30 Jun 2025 10-Q 12 Aug 2025 2025 Q2
Q1 2025 61,819,101 +13,175,785 +27% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 61,819,101 +14,603,985 +31% 31 Dec 2024 10-K 16 Mar 2026 2025 FY
Q3 2024 60,207,717 +15,084,436 +33% 30 Sep 2024 10-Q 14 Nov 2024 2024 Q3
Q2 2024 48,643,316 +4,898,902 +11% 30 Jun 2024 10-Q 14 Aug 2024 2024 Q2
Q1 2024 48,643,316 +5,465,166 +13% 31 Mar 2024 10-Q 09 May 2024 2024 Q1
Q4 2023 47,215,116 0 0% 31 Dec 2023 10-K 31 Mar 2025 2024 FY
Q3 2023 45,123,281 +9,737,699 +28% 30 Sep 2023 10-Q 03 Nov 2023 2023 Q3
Q2 2023 43,744,414 +8,362,671 +24% 30 Jun 2023 10-Q 08 Aug 2023 2023 Q2
Q1 2023 43,178,150 +9,003,350 +26% 31 Mar 2023 10-Q 09 May 2023 2023 Q1
Q4 2022 47,215,116 +15,012,620 +47% 31 Dec 2022 10-K 28 Mar 2024 2023 FY
Q3 2022 35,385,582 +4,023,587 +13% 30 Sep 2022 10-Q 14 Nov 2022 2022 Q3
Q2 2022 35,381,743 +3,911,527 +12% 30 Jun 2022 10-Q 04 Aug 2022 2022 Q2
Q1 2022 34,174,800 +3,674,997 +12% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 32,202,496 +1,851,130 +6.1% 31 Dec 2021 10-K 21 Mar 2023 2022 FY
Q3 2021 31,361,995 +1,110,912 +3.7% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 31,470,216 +2,167,024 +7.4% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 30,499,803 +3,923,844 +15% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 30,351,366 +3,789,188 +14% 31 Dec 2020 10-K 16 Mar 2022 2021 FY
Q3 2020 30,251,083 +7,281,117 +32% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 29,303,192 +7,989,622 +37% 30 Jun 2020 10-Q 07 Aug 2020 2020 Q2
Q1 2020 26,575,959 +5,792,713 +28% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 26,562,178 +5,864,725 +28% 31 Dec 2019 10-K 09 Mar 2021 2020 FY
Q3 2019 22,969,966 +2,836,700 +14% 30 Sep 2019 10-Q 07 Nov 2019 2019 Q3
Q2 2019 21,313,570 +1,182,804 +5.9% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 20,783,246 +652,480 +3.2% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 20,697,453 +1,238,259 +6.4% 31 Dec 2018 10-K 12 Mar 2020 2019 FY
Q3 2018 20,133,266 30 Sep 2018 10-Q 13 Nov 2018 2018 Q3
Q2 2018 20,130,766 30 Jun 2018 10-Q 13 Aug 2018 2018 Q2
Q1 2018 20,130,766 31 Mar 2018 10-Q 14 May 2018 2018 Q1
Q4 2017 19,459,194 31 Dec 2017 10-K 14 Mar 2019 2018 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.